Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119811792 | 11981179 | 2 | F | 201505 | 20160122 | 20160129 | 20160912 | EXP | FR-ASTRAZENECA-2016SE08754 | ASTRAZENECA | 3033.00 | WK | F | Y | 0.00000 | 20160913 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119811792 | 11981179 | 1 | PS | INEXIUM | ESOMEPRAZOLE | 1 | Oral | N | U | 21153 | 40 | MG | QD | ||||||
| 119811792 | 11981179 | 2 | SS | CORDARONE | AMIODARONE HYDROCHLORIDE | 1 | Oral | 200 MG, UNKNOWN FREQUENCY, 5 DAYS PER WEEK | 0 | ||||||||||
| 119811792 | 11981179 | 3 | SS | AMLOR | AMLODIPINE BESYLATE | 1 | Oral | 460 | MG | N | U | 0 | 5 | MG | QD | ||||
| 119811792 | 11981179 | 4 | SS | TEMODAL | TEMOZOLOMIDE | 1 | Oral | 135 MG, UNKNOWN FREQUENCY, 5 DAYS PER WEEK DURING 2 COURSES | 0 | 135 | MG | ||||||||
| 119811792 | 11981179 | 5 | SS | INNOHEP | TINZAPARIN SODIUM | 1 | Subcutaneous | UG/KG | N | 0 | QD | ||||||||
| 119811792 | 11981179 | 6 | SS | KEPPRA | LEVETIRACETAM | 1 | Oral | 0 | 1000 | MG | BID | ||||||||
| 119811792 | 11981179 | 7 | C | CARDENSIEL | BISOPROLOL FUMARATE | 1 | Oral | 0 | 2.5 | MG | QD | ||||||||
| 119811792 | 11981179 | 8 | C | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | 0 | 30 | MG | QD | ||||||||
| 119811792 | 11981179 | 9 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | IF REQUIRED | 0 | |||||||||||
| 119811792 | 11981179 | 10 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | IF REQUIRED | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119811792 | 11981179 | 1 | Gastric ulcer |
| 119811792 | 11981179 | 2 | Atrial fibrillation |
| 119811792 | 11981179 | 3 | Hypertension |
| 119811792 | 11981179 | 4 | Glioblastoma |
| 119811792 | 11981179 | 7 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119811792 | 11981179 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119811792 | 11981179 | Agranulocytosis | |
| 119811792 | 11981179 | Febrile bone marrow aplasia | |
| 119811792 | 11981179 | Glioblastoma | |
| 119811792 | 11981179 | Pancytopenia | |
| 119811792 | 11981179 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119811792 | 11981179 | 1 | 201601 | 0 | ||
| 119811792 | 11981179 | 2 | 201508 | 0 | ||
| 119811792 | 11981179 | 3 | 201508 | 0 | ||
| 119811792 | 11981179 | 4 | 201507 | 201510 | 0 | |
| 119811792 | 11981179 | 5 | 201508 | 20151130 | 0 | |
| 119811792 | 11981179 | 7 | 201508 | 0 |